How to buy Lannett Company stock (LCI)

Lannett Company is a drug manufacturers - specialty & generic business based in the US. Lannett Company shares (LCI) are listed on the NYSE and all prices are listed in US Dollars. Lannett Company employs 564 staff and has a trailing 12-month revenue of around $308.5 million.

Our top picks for where to buy Lannett Company stock

Buy Lannett Company stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Lannett Company stock price (NYSE: LCI)

Use our graph to track the performance of LCI stocks over time.

Lannett Company shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$1.30
200-day moving average more info button	$2.00
Wall St. target price	$4.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-19.14

Is it a good time to buy Lannett Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lannett Company financials

Revenue TTM	$308.5 million
Gross profit TTM	$46.1 million
Return on assets TTM	-7.8%
Return on equity TTM	0%
Profit margin	-62.4%
Book value	$-30.28
Market Capitalization more info button	$7.4 million

TTM: trailing 12 months

Lannett Company share dividends

We're not expecting Lannett Company to pay a dividend over the next 12 months.

Have Lannett Company's shares ever split?

Lannett Company's shares were split on a 1:4 basis on 6 February 2023 . So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lannett Company shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Lannett Company shares which in turn could have impacted Lannett Company's share price.

Lannett Company share price volatility

Over the last 12 months, Lannett Company's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Lannett Company's is 0.9474. This would suggest that Lannett Company's shares are less volatile than average (for this exchange).

Lannett Company overview

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's product portfolio includes Amphetamine IR tablets, Amphetamine ER capsules, Dicyclomine tablets, Fluphenazine tablets, Levothyroxine capsules, Methylphenidate CD capsules, Methylphenidate ER, Posaconazole DR tablets, Probenecid tablets, and Verapamil SR tablets, as well as Numbrino nasal solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, Sinotherapeutics, Respirent Pharmaceuticals Co.

Frequently asked questions

What percentage of Lannett Company is owned by insiders or institutions?
Currently 14.263% of Lannett Company shares are held by insiders and 38.93% by institutions. How many people work for Lannett Company?
Latest data suggests 564 work at Lannett Company. When does the fiscal year end for Lannett Company?
Lannett Company's fiscal year ends in June. Where is Lannett Company based?
Lannett Company's address is: 1150 Northbrook Drive, Trevose, PA, United States, 19053 What is Lannett Company's ISIN number?
Lannett Company's international securities identification number is: US5160121019 What is Lannett Company's CUSIP number?
Lannett Company's Committee on Uniform Securities Identification Procedures number is: 516012101